EDAP TMS (EDAP) 2025 Conference June 05, 2025 04:20 PM ET Speaker0 Okay. Alright. Good afternoon. My name is Michael Sarcone. I'm an analyst on the US Medical Supplies and Devices team, this is day two of the Jefferies twenty twenty five New York Healthcare Conference. This is a session with EDAP Focal One. And with us from the company, we've got Ryan Rhodes, CEO Ken Moback, CFO and John Francis who heads the IR function. Ryan Rhodes is going to give a presentation, some prepared commentary and then we'll o ...

Replimune Group (REPL) 2025 Conference June 05, 2025 04:20 PM ET Speaker0 Well, these guys in the back, they turn it on for you. Okay. The middle, please. Speaker1 I was gonna take this one. Speaker2 This is Speaker1 on a mic. Speaker0 This Okay. Speaker1 You can take a wee bit. Speaker0 Would you like to be in the middle? Nope. K. Speaker2 Rose between two thorns. K. Well said. Alright. Okay. Alright. Welcome everyone to Jefferies twenty twenty five Healthcare Global Conference. My name is Roger Song, one ...

Hyperfine (HYPR) 2025 Conference June 05, 2025 04:20 PM ET Speaker0 Alright. We're kicking off the next session here. My name is Young Lee, one of the med tech analysts at Jefferies, and pleased to be joined by Hyperfine. From the company, we have the CEO to my right, Maria Sainz. I guess I'll just pass the floor off to you for the presentation. Thank you. Speaker1 Thank you, and thank you for, inviting me. I'm very excited to be here. Here are our disclosures. I'm actually very excited to be here today. Hy ...

CorMedix (CRMD) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Good? Alright. Hi, everybody. Try and squeeze in and find a seat where you can. Just a quick look at our forward looking statements. So who is CorMedix? Alright. We are a publicly traded, small cap, commercial stage biotech company, in the process of commercializing our lead product, DefenCath. DefenCath is an FDA approved, first in class, non antibiotic antimicrobial catheter lock solution initially indicated to reduce the incidence of cath ...

I-Mab (IMAB) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Great. I think we can get started. Good afternoon, everyone. Thank you for attending Jefferies Healthcare Conference. My name is Yifan Shi from Jefferies Biotech Research Team. Today, we are very pleased to have Doctor. Sheng Fu, CEO of IMAP, and Doctor. Philip Dennis, CMO of IMAP, in for this session. Welcome. Speaker1 Thank you. Speaker0 So, to get start, so for those who may be less familiar with your story, could you please provide a high l ...

Orchestra BioMed Holdings (OBIO) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Okay, Speaker1 good to go. So thanks everybody for joining for our next session. I'm Matt Taylor, the US Medical Supplies and Devices analyst here at Jefferies. I'm joined by David Hockman, the CEO of Orchestra Lab. Speaker0 Nice to be here. Speaker1 And we have about half an hour for moderated Q and A. And I'll get things rolling here with kind of a high level question. So I think let's start with your business model is rea ...

Foghorn Therapeutics (FHTX) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Good afternoon, everyone. Thank you for attending Jefferies Global Healthcare Conference. My name is Kelly Xu, one of the senior analysts on biotech team. And for this first set of chat session, we are very pleased to have mister Andrew Gostrok, Chief Executive Officer from Falkhawn Therapeutics. Welcome. Speaker1 Thank you. Speaker0 Maybe first we could recap the potential in addressing the chromatin regulatory system and the BA ...

Septerna (SEPN) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Hello, and welcome to the Jefferies twenty twenty five Global Healthcare Conference. My name is Chase Booken with the Jefferies Healthcare Banking team, and it is my great pleasure to introduce Jeff Feiner, CEO of Subturno. Jeff? Speaker1 Okay, thanks Chase and thanks to Jefferies for the invitation to introduce some of you to Subturno for the first time and for others to give you an update. I need to say that my presentation will include so ...

PMV Pharmaceuticals (PMVP) 2025 Conference June 05, 2025 03:45 PM ET Speaker0 Hello, everyone. Thank you so much for joining us at the Jefferies Global Healthcare Conference twenty twenty five. We're kind of winding the day down now, but it's my distinct honor and pleasure to be hosting PMV Pharma. We're gonna get a perspective today from the chief development officer, Deepika Jolotta. Deepika, welcome. Speaker1 Thank you so much. It's a pleasure to be here. Speaker0 So maybe we could just get directly into ...

NN (NNBR) Conference June 05, 2025 03:30 PM ET Speaker0 Afternoon, and welcome to the Noble Capital Markets Virtual Equity Conference. I am Joe Gomes, managing director and senior analyst at Noble Capital. Today, I have the pleasure of introducing NN Inc. Following the presentation, we'll have some time for q and a. NN is a precision component manufacturer with extensive experience in machining, stamping, and precious metal plating. With us today from the company is Harold Beavis, president and CEO Chris Bo ...